Harris v. Corizon of Florida, LLC

District Court, M.D. Florida·Decided July 8, 2022·No. 3:21-cv-00353·Unknown

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA JACKSONVILLE DIVISION

MITCHELL A. HARRIS,

Plaintiff,

v. Case No. 3:21-cv-353-MMH-MCR

THE FLORIDA DEPARTMENT OF CORRECTIONS, et al.,

Defendants. ________________________________

ORDER I. Status Plaintiff Mitchell A. Harris, an inmate in the custody of the Florida Department of Corrections (FDOC), initiated this action on March 29, 2021, by filing a pro se Civil Rights Complaint (Complaint; Doc. 1)1 pursuant to 42 U.S.C. § 1983. Harris is proceeding on an amended complaint (AC; Doc. 59), filed on September 1, 2021. In his AC, Harris presents claims against the following Defendants: (1) the FDOC; (2) Centurion of Florida, LLC (Centurion); and (3) Corizon Health, Inc. (Corizon). Harris, who alleges he suffers from the hepatitis C virus (HCV), asserts that Centurion and Corizon violated the

1 For all pleadings and documents filed in this case, the Court cites to the document and page numbers as assigned by the Court’s Electronic Case Filing System. Eighth Amendment when they allegedly created and implemented a cost- saving policy that sanctioned the delay of medically necessary treatment for

Harris’s HCV infection. Harris also contends that the FDOC violated the Americans with Disabilities Act (ADA) and the Rehabilitation Act (RA) by delaying treatment for his HCV. As relief, Harris seeks compensatory damages, punitive damages, attorney’s fees and costs, and any other

appropriate relief. This matter is before the Court on Defendants’ Motions to Dismiss. See Centurion of Florida, LLC’s Motion to Dismiss Amended Complaint and Incorporated Memorandum of Law (Centurion Motion; Doc. 68); Defendant

Corizon Health, Inc.’s Motion to Dismiss (Corizon Motion; Doc. 69); Motion to Dismiss by Defendant Florida Department of Corrections (FDOC Motion; Doc. 70) (collectively “Motions”). The FDOC also filed an exhibit. See FDOC Motion Ex. 1. Harris filed responses in opposition to the Motions. See Plaintiff’s Motion

in Opposition to Defendants’ Motion to Dismiss (Centurion Response; Doc. 76); Plaintiff’s Motion in Response/Opposition to Defendant Corizon Health, Inc.’s Motion to Dismiss (Corizon Response; Doc. 81); Plaintiff’s Motion in Response/Opposition to Defendant Department of Corrections’ Motion to

Dismiss (FDOC Response; Doc. 84) (collectively “Responses”). Centurion filed 2 a Reply. Defendant’s Reply in Support of Motion to Dismiss (Reply; Doc. 83). And, Harris filed a Surreply. Plaintiff’s Response to Defendant’s Reply in

Support of Defendant’s Motion to Dismiss (Surreply; Doc. 86). Defendants’ Motions are ripe for review. II. Plaintiff’s Allegations2 In his AC, Harris brings three claims. He alleges that: (1) the FDOC

discriminated against inmates with HCV, including Harris, in violation of the ADA (Count One); (2) the FDOC discriminated against inmates with HCV, including Harris, in violation of the RA (Count Two); and (3) Centurion and Corizon each were deliberately indifferent to a serious medical need when they

each enforced a policy that delayed necessary treatment for Harris’s HCV infection in violation of the Eighth Amendment (Count Three).3 AC at 23-34.

2 Because this case is before the Court on Defendants’ Motions to Dismiss, the Court accepts the allegations in Harris’s AC as true and construes them in the light most favorable to Harris. Cinotto v. Delta Air Lines, Inc., 674 F.3d 1285, 1291 (11th Cir. 2012). Moreover, to the extent Harris’s claims in his initial Complaint conflict with those in his AC, the Court accepts the claims in his AC as true. See TVPX ARS, Inc. v. Genworth Life & Annuity Ins. Co., 959 F.3d 1318, 1327 (11th Cir. 2020). 3 Harris explicitly pleads two counts under the ADA and RA against the FDOC in his AC. Contrary to his suggestion in the FDOC Response, Harris failed to allege an Eighth Amendment claim against the FDOC. To the extent his arguments there can be construed as a request to amend his pleadings to include an Eighth Amendment claim against the FDOC, his request is improper. A request for affirmative relief, such as a request for leave to amend a pleading, is not properly made when simply included in a response to a motion. See Fed. R. Civ. P. 7(b); see also Rosenberg v. Gould, 554 F.3d 962, 965 (11th Cir. 2009) (“Where a request for 3 As to the specific underlying facts supporting his claims, Harris asserts that chronic HCV occurs when an individual has “a detectable HCV viral level”

six months after exposure to the virus. Id. at 6. Chronic HCV causes liver inflammation and impairs liver function, and ultimately progresses to fibrosis, or scarring of the liver. Id. Severe fibrosis “may reach cirrhosis within as short a timeframe as one year.” Id. at 7. Cirrhosis of the liver results in numerous

complications, including liver cancer, jaundice, kidney disease, and seizures. Id. at 7-8. The United States Food and Drug Administration approved direct-acting antivirals (DAA) for the treatment of HCV beginning in 2013. Id. at 11.

Treatment of HCV with DAAs has been recognized as the standard of care since 2014. Id. at 12. Approximately 90% of HCV patients treated with DAAs were cured of HCV, whereas previous forms of treatment only cured a third of patients. Id. at 11. DAA treatment can reduce liver inflammation and slow the

progression of fibrosis to cirrhosis. Id. at 12. Its other benefits include a 70% reduction in the risk of liver cancer and a 90% reduction in the risk of “liver-

leave to file an amended complaint simply is imbedded within an opposition memorandum, the issue has not been raised properly.”) (quoting Posner v. Essex Ins. Co., 178 F.3d 1209, 1222 (11th Cir. 1999)). 4 related mortality.” Id. However, delaying a DAA treatment “increases the risk that the treatment will be ineffective.” Id. at 13.

Harris entered FDOC custody on November 8, 2010. Id. at 17. He received an HCV diagnosis in September 2011. Id. Defendants did not begin providing DAA treatment to Harris until April 2018. Id. at 18. In October 2018, seven years after his diagnosis, Harris was given a FibroTest to determine his

METVAIR score. Id. at 19. According to Harris, a METVAIR score measures the extent of liver scarring in a patient. Id. at 7. METVAIR scores can range from F0, indicating no liver fibrosis, to F4, indicating cirrhosis of the liver. Id. The test measured his fibrosis level to be F4, meaning Harris had cirrhosis. Id.

at 19. Harris contends he developed liver disease and cirrhosis because of the refusal to timely provide him with DAA treatment. Id. at 18. According to Harris, from September 2011 to June 2019, “routine blood draws” were used to monitor his HCV. Id. at 18. Throughout his incarceration,

Harris “regularly inquired about the condition of his liver and requested HCV treatment[] but was consistently denied such treatment.” Id. He did not know about the severity of his HCV because he “was told repeatedly . . . that he had nothing to worry about, his [HCV] was under control and being monitored and

if he needed treatment[,] he would be provided treatment.” Id. 5 Harris asserts the FDOC established and enforced a policy of delaying DAA treatments for inmates with HCV. Id. at 17. Centurion and Corizon,4

medical contractors for the FDOC, also knew about and enforced the policy. Id. at 14-15. The FDOC, Centurion, and Corizon maintained the policy despite their knowledge of the serious risks to inmates with HCV, including Harris. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Harris v. Corizon of Florida, LLC, (M.D. Fla. 2022).

Harris v. Corizon of Florida, LLC (Harris v. Corizon of Florida, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Arlene M. Stone v. First Union Corporation
371 F.3d 1305 (Eleventh Circuit, 2004)
Jim E. Chandler v. James Crosby
379 F.3d 1278 (Eleventh Circuit, 2004)
Goebert v. Lee County
510 F.3d 1312 (Eleventh Circuit, 2007)
McNair v. Allen
515 F.3d 1168 (Eleventh Circuit, 2008)
Bryant v. Rich
530 F.3d 1368 (Eleventh Circuit, 2008)
Turner v. Burnside
541 F.3d 1077 (Eleventh Circuit, 2008)
Rosenberg v. Gould
554 F.3d 962 (Eleventh Circuit, 2009)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Porter v. Nussle
534 U.S. 516 (Supreme Court, 2002)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Parzyck v. Prison Health Services, Inc.
627 F.3d 1215 (Eleventh Circuit, 2010)
Cinotto v. Delta Air Lines, Inc.
674 F.3d 1285 (Eleventh Circuit, 2012)
Dion Strong v. Alphonso David
297 F.3d 646 (Seventh Circuit, 2002)
Christopher Troy Myles v. Anthony Green
476 F. App'x 364 (Eleventh Circuit, 2012)
White v. Moore
789 So. 2d 1118 (District Court of Appeal of Florida, 2001)
Moliere Dimanche, Jr. v. Jerry Brown
783 F.3d 1204 (Eleventh Circuit, 2015)
Shawn Wayne Whatley v. Warden, Ware State Prison
802 F.3d 1205 (Eleventh Circuit, 2015)